1. Home
  2. PLUS vs VERA Comparison

PLUS vs VERA Comparison

Compare PLUS & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ePlus inc.

PLUS

ePlus inc.

HOLD

Current Price

$89.52

Market Cap

2.4B

Sector

Technology

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$53.76

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLUS
VERA
Founded
1990
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
1.5B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
PLUS
VERA
Price
$89.52
$53.76
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$76.60
AVG Volume (30 Days)
200.3K
1.8M
Earning Date
02-04-2026
11-05-2025
Dividend Yield
1.11%
N/A
EPS Growth
14.25
N/A
EPS
4.60
N/A
Revenue
$2,285,906,000.00
N/A
Revenue This Year
$14.37
N/A
Revenue Next Year
$3.17
N/A
P/E Ratio
$18.44
N/A
Revenue Growth
9.24
N/A
52 Week Low
$53.83
$18.53
52 Week High
$93.98
$56.05

Technical Indicators

Market Signals
Indicator
PLUS
VERA
Relative Strength Index (RSI) 54.70 80.23
Support Level $87.62 $47.22
Resistance Level $91.41 $56.05
Average True Range (ATR) 2.38 2.89
MACD -0.61 0.39
Stochastic Oscillator 32.68 85.61

Price Performance

Historical Comparison
PLUS
VERA

About PLUS ePlus inc.

ePlus Inc is a provider of technology solutions across the IT spectrum, spanning security, cloud, data center, networking, collaboration, AI, service provider, and critical infrastructure, and emerging solutions, to domestic and foreign organizations across all industry segments. Its solutions leverage a broad range of professional, consultative, and managed services across the technology spectrum. The company possesses top-level engineering certifications with a broad range of IT technologies that enable the company to offer multi-vendor IT solutions that are optimized for each of its customers' specific requirements. It also offers a wide portfolio of technology and other capital asset financing solutions to customers across commercial and government enterprises, designing programs.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: